Advanced search
Publication Cover
Journal of Medical Economics Volume 23, 2020 - Issue 8
Submit an article Journal homepage
3,753
Views
6
CrossRef citations to date
0
Altmetric
Respiratory Medicine

Cost effectiveness of benralizumab for severe, uncontrolled oral corticosteroid–dependent asthma in Sweden

Maria AnderssonAstraZeneca Nordic-Baltic, Södertälje, Sweden; Correspondence[email protected]
,
Christer JansonDepartment of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden; ORCID Iconhttp://orcid.org/0000-0001-5093-6980
ORCID Icon,
Thomas KristensenAstraZeneca Nordic-Baltic, Södertälje, Sweden;
,
Agota SzendeCovance, Leeds, UK; ORCID Iconhttp://orcid.org/0000-0002-5880-3354
ORCID Icon &
Sarowar GolamGlobal Market Access and Pricing, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden
Pages 877-884 | Received 19 Mar 2020, Accepted 16 Apr 2020, Published online: 13 May 2020

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.